AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%

Market Cap$460.2B

LTM Free Cash Flow margin

13.5%

5Y avg

11.8%

Drug Manufacturers - General industry median

20.3%

Stock quality & Intrinsic value

7/10

(0.6%) overvalued

is (60.2%) overvalued

undervalued stocks

Start beating the S&P 500

AstraZeneca PLC Free Cash Flow margin

Annual

Quarterly

LTM

Industry median

Company stand-alone

AZN

Healthcare

Crunching data... Almost there!

	Dec'04	Dec'05	Dec'06	Dec'07	Dec'08	Dec'09	Dec'10	Dec'11	Dec'12	Dec'13	Dec'14	Dec'15	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23
Free Cash Flow margin	21.2%	24.1%	24.0%	19.7%	14.9%	26.8%	24.8%	19.4%	8.3%	20.8%	16.5%	2.2%	8.0%	8.7%	5.6%	2.1%	8.2%	10.1%	16.3%	14.3%

AZN

Key metrics and insights to make informed decisions.

View full analysis

Overvalued or undervalued?

Check the intrinsic value for AZN and see if it's the right time to invest.

AstraZeneca PLC (AZN) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

AZN key stats

USD

Millions

Billions

Annual

Quarterly

Trailing

Key stats

Income statement

Balance sheet

Cash Flow Statement

Valuation

Ratios

Per share

Per employee

Dividends & Yields

Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

FAQ

1) What is AstraZeneca PLC's Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 13.5%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Free Cash Flow margin for AstraZeneca PLC have been 13.6% over the past three years, and 12.4% over the past five years.

2) Is AstraZeneca PLC's Free Cash Flow margin Good?

As of today, AstraZeneca PLC's Free Cash Flow margin is 13.5%, which is lower than industry median of 20.3%. It indicates that AstraZeneca PLC's Free Cash Flow margin is Bad.

3) How does AstraZeneca PLC's Free Cash Flow margin compare to its peers?

As of today, AstraZeneca PLC's Free Cash Flow margin is 13.5%, which is lower than peer median of 27.9%. The list of peers includes GILD, MRK, ABBV, AMGN, BMY, NVS, JNJ, PFE, LLY, SNY.